• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Regulation of immune response by components of the complement cascade and their activated fragments.

作者信息

Weigle W O, Goodman M G, Morgan E L, Hugli T E

出版信息

Springer Semin Immunopathol. 1983;6(2-3):173-94. doi: 10.1007/BF00205872.

DOI:10.1007/BF00205872
PMID:6356429
Abstract
摘要

相似文献

1
Regulation of immune response by components of the complement cascade and their activated fragments.补体级联反应成分及其活化片段对免疫反应的调节。
Springer Semin Immunopathol. 1983;6(2-3):173-94. doi: 10.1007/BF00205872.
2
Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.过敏毒素在相互作用细胞微环境中对免疫反应的调节。
Fed Proc. 1982 Dec;41(14):3099-103.
3
Complement ligand-receptor interactions that mediate biological responses.介导生物反应的补体配体-受体相互作用。
Annu Rev Immunol. 1983;1:243-71. doi: 10.1146/annurev.iy.01.040183.001331.
4
New developments in immunopathology with special reference to complement and immune complexes.免疫病理学的新进展，特别涉及补体和免疫复合物。
Int Arch Allergy Appl Immunol. 1985;77(1-2):89-95. doi: 10.1159/000233759.
5
Role of complement in the immune response.补体在免疫反应中的作用。
Fed Proc. 1984 Jul;43(10):2548-52.
6
How do complement components and fragments affect cellular immunological function?补体成分和片段如何影响细胞免疫功能？
J Trauma. 1984 Sep;24(9 Suppl):S118-24.
7
Complement and the damaging effects of cardiopulmonary bypass.补体与体外循环的损伤作用
Thorax. 1983 May;38(5):321-5. doi: 10.1136/thx.38.5.321.
8
The role of complement and its receptor in the elimination of immune complexes.补体及其受体在清除免疫复合物中的作用。
N Engl J Med. 1986 Aug 21;315(8):488-95. doi: 10.1056/NEJM198608213150805.
9
Bioactive complement fragments in immunoregulation.免疫调节中的生物活性补体片段
Immunol Lett. 1985;9(4):207-13. doi: 10.1016/0165-2478(85)90034-3.
10
Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.表面结合的C3或C5对经典补体途径C3转化酶活性的调节。
J Immunol. 1980 Feb;124(2):520-6.

引用本文的文献

1
The complement system at the embryo implantation site: friend or foe?胚胎着床部位的补体系统：是敌是友？
Front Immunol. 2012 Mar 19;3:55. doi: 10.3389/fimmu.2012.00055. eCollection 2012.
2
Prevalence of foam cells and helper-T cells in atherosclerotic plaques of Korean patients with carotid atheroma.韩国颈动脉粥样硬化患者动脉粥样硬化斑块中泡沫细胞和辅助性T细胞的患病率。
Korean J Intern Med. 2000 Jul;15(2):117-21. doi: 10.3904/kjim.2000.15.2.117.
3
Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system.

本文引用的文献

1
Phagocytosis of immune complexes mediated by IgM and C3 receptors by macrophages from mice treated with glycogen.糖原处理的小鼠巨噬细胞通过IgM和C3受体介导的免疫复合物吞噬作用
J Immunol. 1981 Jan;126(1):127-30.
2
Effects of soluble immune complexes on Fc receptor- and C3b receptor-mediated phagocytosis by macrophages.可溶性免疫复合物对巨噬细胞Fc受体和C3b受体介导的吞噬作用的影响。
J Exp Med. 1980 Oct 1;152(4):905-19. doi: 10.1084/jem.152.4.905.
3
Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragments.
针对流感病毒的先天性和获得性体液免疫由免疫系统的不同分支介导。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2250-5. doi: 10.1073/pnas.96.5.2250.
4
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.补体受体1和2缺陷小鼠的体液免疫反应明显受损。
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3357-61. doi: 10.1073/pnas.93.8.3357.
5
Cytokines and other mediators in rheumatoid arthritis.类风湿关节炎中的细胞因子及其他介质
Springer Semin Immunopathol. 1984;7(4):387-413. doi: 10.1007/BF00201968.
6
Structure and function of the anaphylatoxins.过敏毒素的结构与功能。
Springer Semin Immunopathol. 1984;7(2-3):193-219. doi: 10.1007/BF01893020.
7
The chemistry and biology of complement receptors.补体受体的化学与生物学
Springer Semin Immunopathol. 1984;7(2-3):221-49. doi: 10.1007/BF01893021.
8
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.人类B淋巴细胞的爱泼斯坦-巴尔病毒受体是C3d受体CR2。
Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510-4. doi: 10.1073/pnas.81.14.4510.
9
Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein.通过亲和层析法分离补体片段-iC3b结合蛋白。鉴定p150,95为一种iC3b结合蛋白。
Biochem J. 1985 Oct 1;231(1):233-6. doi: 10.1042/bj2310233.
10
Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba.替代补体途径的激活：一种测量Ba片段的新技术的临床应用
J Clin Pathol. 1987 Oct;40(10):1235-9. doi: 10.1136/jcp.40.10.1235.
免疫反应的调节。I. Fc片段对体内和体外免疫反应的增强作用。
J Exp Med. 1980 Jul 1;152(1):113-23. doi: 10.1084/jem.152.1.113.
4
Lack of binding of human C3, in its native state, to C3b receptors.天然状态下的人C3与C3b受体缺乏结合。
J Immunol. 1981 Oct;127(4):1329-34.
5
Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.关于补体成分C3可能参与巨噬细胞酸性水解酶分泌起始过程的研究。I. 几种促分泌剂的酶释放能力与补体激活能力之间的相关性。
Immunology. 1981 Sep;44(1):29-39.
6
Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.靶细胞结合的C3bi和C3d与人淋巴细胞受体的相互作用。抗体介导的细胞毒性增强。
J Exp Med. 1981 Jun 1;153(6):1592-603. doi: 10.1084/jem.153.6.1592.
7
The third component of complement inhibits human lymphocyte blastogenesis.补体的第三成分可抑制人淋巴细胞的增殖。
J Immunol. 1981 Apr;126(4):1586-91.
8
Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.在鼠巨噬细胞上证实存在人C5a过敏毒素的特异性受体。
J Exp Med. 1982 Jul 1;156(1):68-78. doi: 10.1084/jem.156.1.68.
9
Modulation of human lymphocyte function by C3a and C3a(70-77).C3a和C3a(70 - 77)对人淋巴细胞功能的调节
J Exp Med. 1982 Sep 1;156(3):756-65. doi: 10.1084/jem.156.3.756.
10
The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.C3a、C4a和C5a的过敏毒素及趋化功能的结构基础。
Crit Rev Immunol. 1981 Feb;1(4):321-66.